ADVANTAGES OF COMBINATION THERAPY OF HYPERTENSION WITH CALCIUM CHANNEL BLOCKER AND ANGIOTENSIN-CONVERTING ENZYME INHIBITOR IN PATIENTS WITH IMPAIRED RENAL FUNCTION

ADVANTAGES OF COMBINATION THERAPY OF HYPERTENSION WITH CALCIUM CHANNEL BLOCKER AND ANGIOTENSIN-CONVERTING ENZYME INHIBITOR IN PATIENTS WITH IMPAIRED RENAL FUNCTION

Show other versions (1)

<p>Up-to-date data on combination therapy of arterial hypertension in patients with chronic kidney disease are presented. Special attention is paid to the fixed combination of calcium antagonist lercanidipine and angiotensin-converting enzyme inhibitor enalapril.</p>

Bibliographic Details
Main Author:	N. A. Dzhaiani
Format:	Article
Language:	English
Published:	Столичная издательская компания 2015-09-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	хроническая болезнь почек комбинированная антигипертензивная терапия антагонист кальция ингибитор ангиотензинпревращающего фермента
Online Access:	http://www.rpcardio.ru/jour/article/view/29

Similar Items

AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND CALCIUM ANTAGONIST COMBINATION IN PHARMACOTHERAPY OF ARTERIAL HYPERTENSION
by: L. L. Kirichenko, et al.
Published: (2014-02-01)

Pri vsem bogatstve vybora drugoy al'ternativy net Issledovanie ETNA Plyus (ETNA v zhizni vracha polikliniki)
by: I E Chazova, et al.
Published: (2006-06-01)

Kombinirovannaya terapiya ingibitorom angiotenzinprevrashchayushchego fermenta i diuretikom
by: I E Chazova, et al.
Published: (2006-06-01)

An angiotensin-converting enzyme inhibitor in the combination treatment of rheumatoid arthritis
by: E. B. Komarova, et al.
Published: (2017-09-01)

Lupus Nephritis in Pediatric Practice: 20-Year Experience in Care
by: G. A. Makovetskaya, et al.
Published: (2021-01-01)

VESSEL WALL STIFFNESS IN ARTERIAL HYPERTENSION AND OPPORTUNITIES FOR ITS MODULATION
by: L. L. Kirichenko, et al.
Published: (2016-12-01)

Sravnitel'naya otsenka antigipertenzivnoy effektivnosti lozartana i ego fiksirovannoy kombinatsii s gidrokhlortiazidom pri 24-nedel'noy terapii u bol'nykh gipertonicheskoy bolezn'yu
by: L G Ratova, et al.
Published: (2004-03-01)

A META-ANALYSIS REPORTING EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTSWITHOUT HEART FAILURE
by: G. Savarese, et al.
Published: (2015-09-01)

LERCANIDIPINE, CALCIUM CHANNEL BLOCKER OF THE THIRD GENERATION: NEW POSSIBILITIES IN THE TREATMENT OF ARTERIAL HYPERTENSION
by: O. D. Ostroumova, et al.
Published: (2015-09-01)

Cardiorenal syndrome in patients with heart failure as a stage of the cardiorenal continuum (part 2): prognosis, prevention and treatment
by: E. V. Reznik, et al.
Published: (2019-03-01)

FIXED COMBINATION OF THE CALCIUM CHANNEL BLOCKER LERCANIDIPINE AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR ENALAPRIL: POSSIBILITY OF USAGE
by: O. D. Ostroumova, et al.
Published: (2015-09-01)

Clinical pharmacology of the combination of ACE inhibitors and calcium antagonists: benefits of the perindopril arginine and amlodipine combination
by: M. V. Leonova
Published: (1970-01-01)

ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: IS THERE A REASON TO CONSIDER AN EQUIVALENCE OF TWO DRUG CLASSES FROM THE EVIDENCE BASED MEDICINE STANDPOINT
by: S. Yu. Martsevich
Published: (2015-09-01)

COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS WITH HEART FAILURE AND PRESERVED SYSTOLIC FUNCTION: IS THERE A PLACE FOR AN INFORMED CHOICE?
by: I. V. Zhirov, et al.
Published: (2013-12-01)

ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN ACUTE MYOCARDIAL INFARCTION: WHEN TO START THERAPY AND WHICH DRUG TO USE?
by: S. Y. Martsevich, et al.
Published: (2015-12-01)

Effects of a fixed-dose combination of enalapnl and hydrochlorothiazide on carotid intima-media thickness in patients with arterial hypertension
by: O. D. Ostroumova, et al.
Published: (2009-08-01)

COMPARATIVE EFFECTIVENESS OF FIXED-DOSE COMBINATIONS OF LISINOPRIL/AMLODIPINE AND ENALAPRIL/HYDROCHLOROTHIAZIDE
by: S. V. Nedogoda, et al.
Published: (2013-04-01)

ВЛИЯНИЕ КОМБИНИРОВАННОЙ ТЕРАПИИ НА ЦЕНТРАЛЬНОЕ АРТЕРИАЛЬНОЕ ДАВЛЕНИЕ И АРТЕРИАЛЬНУЮ РИГИДНОСТЬ
Published: (2016-12-01)

In the wake of the latest clinical guidelines - mineralocorticoid receptor antagonists in the treatment of chronic heart failure
by: I. V. Zhirov, et al.
Published: (2015-12-01)

Functionally-morphological kidneys condition in patients with rheumatoid arthritis
by: M. I. Kalyuzhina, et al.
Published: (2009-08-01)

PHARMACOECONOMIC ANALYSIS OF ANTIHYPERTENSIVE DRUG COMBINATIONS USE
by: E. I. Tarlovskaya, et al.
Published: (2015-09-01)

Effect of angiotensin II receptor blocker therapy on markers of fibrosis and immune inflammation in hypertensive patients with chronic kidney disease after ischemic stroke
by: O. A. Osipova, et al.
Published: (2021-11-01)

TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS
by: L. N. Malay, et al.
Published: (2016-01-01)

Pharmacogenetics in treatment of anthracycline-induced cardiotoxicity in women without prior cardiovascular diseases
by: E. V. Grakova, et al.
Published: (2023-01-01)

ДИСФУНКЦИЯ ПОЧЕК КАК ПРЕДИКТОР ПРОГРЕССИРОВАНИЯ АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИИ
by: О. В. Заблоцкая, et al.
Published: (2023-09-01)

Acquisition of renin-angiotensin-aldosterone system inhibitors for the treatment of cardiovascular diseases in regions of the Far Eastern Federal District
by: M. S. Soboleva, et al.
Published: (2020-04-01)

EXPERIENCE OF TREATMENT OF PATIENTS WITH CHRONIC KIDNEY DISEASE USING THE METHOD OF PERITONEAL DIALYSIS
by: Татьяна Владимировна Мироненко, et al.
Published: (2021-11-01)

SEARCH FOR UNIVERSAL COMBINED ANTIHYPERTENSIVE THERAPY WITHIN LIMITED DATA ON THE COMPARATIVE EFFICACY OF ANTIHYPERTENSIVE AGENTS
by: S. R. Gilyarevskiy
Published: (2015-09-01)

Two strategies for arterial hypertension treatment in patients with secondary chronic pyelonephritis
by: M. E. Statsenko, et al.
Published: (2011-08-01)

Adding а thiazide diuretic to combined antihypertensive therapy is clinically reasonable
by: V. I. Makolkin
Published: (2008-12-01)

Controlled arterial hypertension and adverse event free survival rate in heart recipients
by: A. О. Shevchenko, et al.
Published: (2018-08-01)

Patients with CKD-5D and COVID infection. Individual organizational and clinical issues of therapy
by: P. V. Morinets, et al.
Published: (2021-05-01)

THE EFFICACY OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANTAGONISTS OF THE RECEPTORS OF THE 1ST TYPE OF ANGIOTENSIN II IN PATIENTS WITH CORONARY ARTERY DISEASE POSTINFARCTION CARDIOSCLEROSIS COMBINED WITH DIABETES MELLITUS TYPE 2 AND ARTERIAL HYPERTENSION
by: Zarina Vyacheslavovna Bitarovа, et al.
Published: (2016-07-01)

О ФАКТОРАХ РИСКА, ОСОБЕННОСТЯХ ТЕЧЕНИЯ И КРИТЕРИЯХ ДИАГНОСТИКИ ИШЕМИЧЕСКОЙ БОЛЕЗНИ ПОЧЕК У БОЛЬНЫХ ИШЕМИЧЕСКОЙ БОЛЕЗНЬЮ СЕРДЦА
by: О. Н. Сигитова, et al.
Published: (2013-10-01)

Modern concept — renal continuum (acute kidney injury, acute kidney disease, chronic kidney disease)
by: A. M. Shutov, et al.
Published: (2021-03-01)

Increase in the frequency of lower extremity venous reflux in male patients with hypertension receiving combination of an angiotensin-converting enzyme inhibitor and a calcium channel blocker
by: S. V. Letyagina, et al.
Published: (2021-02-01)

THE CAPABILITIES OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CLINICAL PRACTICE: FOCUS ON VASOPROTECTION
by: D. B. Nebieridze, et al.
Published: (2015-12-01)

Pleiotropic effects of antihypertensive therapy variants
by: S. V. Malchikova, et al.
Published: (2009-04-01)

Comparative effectiveness of fixed combinations of various ramipril and hydrochlorothiazide doses
by: I. E. Chazova, et al.
Published: (2010-08-01)

THE APPLICATION OF COMBINED PREPARATIONS WITH CONSTANT DOSES OF ANTIHYPERTENSIVE DRUGS AS THE INITIAL TACTICS OF TREATMENT AT HIGH BLOOD PRESSURE LEVEL: PROVEN FACTS AND EXPERT’S OPINION
by: S. R. Gilyarevskij, et al.
Published: (2021-05-01)